Nephron-sparing surgery for XXXX .

@entity1 @entity8 @entity101 @entity548 @entity417 @entity5 @entity1457 @entity2916 @entity158 @entity1011 @entity359 @entity811 @entity703
OBJECTIVES: @entity359 ( @entity359 ) is a @entity703 that may require treatment because of associated local complications. The present study was undertaken to evaluate the efficacy of nephron-sparing surgery (NSS) in the management of @entity8 , with respect to the long-term preservation of renal function and absence of @entity5 recurrence. METHODS: From 1980 to 1997, 27 @entity1 underwent NSS for treatment of @entity8 . The clinical presentation, surgical approach, and outcome in these @entity1 were analyzed. Surgical treatment for @entity8 was indicated because of associated symptoms, size of 4.5 cm or greater, and/or suspicion of @entity8 . RESULTS: In symptomatic @entity1 (52%) the most common presenting signs or symptoms were @entity158 (50%), @entity548 or @entity1457 (43%), @entity811 (36%), @entity101 (7%), palpable mass (7%), and @entity417 (7%). Two @entity1 had @entity2916 . Fifteen @entity1 had a solitary functioning kidney (group I), 6 @entity1 had an @entity8 (group II), and 6 @entity1 had a normal contralateral kidney (group III). All operations were performed in situ. There were no operative deaths. All operated kidneys functioned postoperatively, and no @entity1 required dialysis. The mean postoperative serum @entity1011 level in groups I, II, and III was 1.81, 0.98, and 0.97 mg/dL, respectively. No @entity1 have developed recurrent @entity359 , related symptoms, or required dialysis with follow-up to 177 months (median 39). CONCLUSIONS: When surgical treatment for @entity8 is indicated, NSS can be performed with a high success rate even in @entity1 with a very large @entity5 involving a solitary kidney.
